Antivirals for pandemic influenza: guidance on developing a distribution and dispensing program
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
National Academies Press
c2008
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | x, 122 p |
| ISBN: | 0309118662 9780309118668 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044108819 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 0309118662 |9 0-309-11866-2 | ||
| 020 | |a 9780309118668 |9 978-0-309-11866-8 | ||
| 035 | |a (ZDB-30-PAD)EBC3378374 | ||
| 035 | |a (ZDB-89-EBL)EBL3378374 | ||
| 035 | |a (OCoLC)568043972 | ||
| 035 | |a (DE-599)BVBBV044108819 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 614.518 |2 22 | |
| 110 | 2 | |a Institute of Medicine (U.S.) |b Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Antivirals for pandemic influenza |b guidance on developing a distribution and dispensing program |c Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, DC |b National Academies Press |c c2008 | |
| 300 | |a x, 122 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 650 | 4 | |a Antiviral agents |x Effectiveness | |
| 650 | 4 | |a Antiviral agents | |
| 650 | 4 | |a Epidemics |x Prevention | |
| 650 | 4 | |a Influenza |x Prevention | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029515664 | ||
Datensatz im Suchindex
| _version_ | 1804177182608588802 |
|---|---|
| any_adam_object | |
| author_corporate | Institute of Medicine (U.S.) Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic |
| author_corporate_role | aut |
| author_facet | Institute of Medicine (U.S.) Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic |
| author_sort | Institute of Medicine (U.S.) Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic |
| building | Verbundindex |
| bvnumber | BV044108819 |
| collection | ZDB-30-PAD |
| ctrlnum | (ZDB-30-PAD)EBC3378374 (ZDB-89-EBL)EBL3378374 (OCoLC)568043972 (DE-599)BVBBV044108819 |
| dewey-full | 614.518 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.518 |
| dewey-search | 614.518 |
| dewey-sort | 3614.518 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01425nmm a2200361zc 4500</leader><controlfield tag="001">BV044108819</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309118662</subfield><subfield code="9">0-309-11866-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309118668</subfield><subfield code="9">978-0-309-11866-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3378374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3378374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)568043972</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044108819</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">614.518</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antivirals for pandemic influenza</subfield><subfield code="b">guidance on developing a distribution and dispensing program</subfield><subfield code="c">Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 122 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral agents</subfield><subfield code="x">Effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epidemics</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Influenza</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029515664</subfield></datafield></record></collection> |
| id | DE-604.BV044108819 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:54Z |
| institution | BVB |
| isbn | 0309118662 9780309118668 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029515664 |
| oclc_num | 568043972 |
| open_access_boolean | |
| physical | x, 122 p |
| psigel | ZDB-30-PAD |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Institute of Medicine (U.S.) Committee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic Verfasser aut Antivirals for pandemic influenza guidance on developing a distribution and dispensing program Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies Washington, DC National Academies Press c2008 x, 122 p txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Antiviral agents Effectiveness Antiviral agents Epidemics Prevention Influenza Prevention |
| spellingShingle | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program Antiviral agents Effectiveness Antiviral agents Epidemics Prevention Influenza Prevention |
| title | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program |
| title_auth | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program |
| title_exact_search | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program |
| title_full | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| title_fullStr | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| title_full_unstemmed | Antivirals for pandemic influenza guidance on developing a distribution and dispensing program Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| title_short | Antivirals for pandemic influenza |
| title_sort | antivirals for pandemic influenza guidance on developing a distribution and dispensing program |
| title_sub | guidance on developing a distribution and dispensing program |
| topic | Antiviral agents Effectiveness Antiviral agents Epidemics Prevention Influenza Prevention |
| topic_facet | Antiviral agents Effectiveness Antiviral agents Epidemics Prevention Influenza Prevention |
| work_keys_str_mv | AT instituteofmedicineuscommitteeonimplementionofantiviralmedicationstrategiesforaninfluenzapandemic antiviralsforpandemicinfluenzaguidanceondevelopingadistributionanddispensingprogram |